Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model (human apoB transgenic mice)
PubMed 15045696 · doi:10.1016/j.metabol.2003.10.031
What was done
Researchers evaluated the kinetics of 6 human LDL fractions varying in particle diameter from 251 to 265 Å following intravenous injection into human apolipoprotein B (apoB) transgenic mice. A multicompartmental model was fitted to clearance data using standard nonlinear regression via SAAM II to estimate fractional catabolic rates (FCR) and intravascular-extravascular exchange parameters.
What was found
Smaller LDL particles (251 to 257 Å) had a significantly slower FCR (0.050 ± 0.045 h⁻¹) compared with larger particles (262 to 265 Å; 0.134 ± 0.015 h⁻¹, P < .03). FCR correlated with peak LDL diameter (R² = .71, P < .034). Slower intravascular-extravascular exchange occurred for smaller LDL based on equilibration parameters: k(2,1) and k(1,2) were 0.255 h⁻¹ and 0.105 h⁻¹ for smaller LDL versus 0.277 h⁻¹ and 0.248 h⁻¹ for larger LDL (P < .01).
Why it matters
The findings provide kinetic evidence that smaller LDL particles have intrinsically slower plasma clearance and extravascular exchange, supporting a mechanistic rationale for the prolonged residence time and atherogenicity of small dense LDL.
Limits
The study was conducted in a transgenic mouse model rather than humans, and the total number of animal subjects is not reported in the abstract. Only 6 human LDL fractions spanning a narrow size range (251–265 Å) were evaluated, and underlying structural or receptor-level mechanisms were not directly identified.
Cited by
- supports Statins lower larger, cholesterol-rich LDL particles more efficiently than smaller, denser LDL particles.